C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2011
10/20/2011	US20110256608 Modified Variant Bowman Birk Protease Inhibitors
10/20/2011	US20110256607 Homing endonucleases
10/20/2011	US20110256604 Generation of asporogenous solventogenic clostridia
10/20/2011	US20110256601 Modification of hydrogenase activities in thermophilic bacteria to enhance ethanol production
10/20/2011	US20110256589 T7 rna polymerase variants with enhanced thermostability
10/20/2011	US20110256587 High affinity human antibodies to human nerve growth factor
10/20/2011	US20110256585 Mutant penicillin g acylases
10/20/2011	US20110256571 Proteins
10/20/2011	US20110256554 Methods for predicting pregnancy outcome in a subject by hcg assay
10/20/2011	US20110256546 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors
10/20/2011	US20110256544 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
10/20/2011	US20110256543 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
10/20/2011	US20110256533 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
10/20/2011	US20110256260 Methods and compositions for synthesis of long chain polyunsaturatd fatty acids
10/20/2011	US20110256182 Genes encoding major capsid protein l1 of human papilloma virus
10/20/2011	US20110256180 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof
10/20/2011	US20110256175 Amino lipids and methods for the delivery of nucleic acids
10/20/2011	US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011	US20110256166 Multivalent vaccines comprising recombinant viral vectors
10/20/2011	US20110256154 Anti-erbb3 antibodies
10/20/2011	US20110256153 CD37-Binding Molecules and Immunoconjugates Thereof
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256145 Connective Tissue Growth Factor-3 (CTGF-3)
10/20/2011	US20110256138 Amyloid-beta binding proteins
10/20/2011	US20110256137 Pharmaceutical composition comprising a bispecific antibody for epcam
10/20/2011	US20110256133 Anti-polyubiquitin antibodies and methods of use
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256120 Methods and Compositions for Reducing Amyloid Beta Levels
10/20/2011	US20110256119 Novel uses of grs proteins or fragments thereof
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	US20110256090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110256056 Monoclonal Antibodies Against HER2 Antigens, and Uses Therefor
10/20/2011	US20110254948 Method and device for selectively targeting cells within a three -dimensional specimen
10/20/2011	CA2832672A1 Bi-functional complexes and methods for making and using such complexes
10/20/2011	CA2796363A1 Method for producing 1,5-pentanediamine
10/20/2011	CA2796175A1 Capping-prone rna polymerase enzymes and their applications
10/20/2011	CA2796118A1 Microorganisms and methods for the production of ethylene glycol
10/20/2011	CA2796010A1 Trail r2-specific multimeric scaffolds
10/20/2011	CA2795953A1 Antibodies for the treatment of clostridium difficile-associated infection and disease
10/20/2011	CA2795806A1 Polypeptides having glucoamylase activity and polynucleotides encoding same
10/20/2011	CA2795643A1 Methods for generating endogenously tagged protein
10/20/2011	CA2795636A1 Use of endogenous promoters to express heterologous proteins
10/20/2011	CA2795325A1 Fibronectin type iii domain-based multimeric scaffolds
10/20/2011	CA2794843A1 Industrial yeast capable of producing ethanol from at least one pentose
10/20/2011	CA2793451A1 Aptamers to .beta.-ngf and their use in treating .beta.-ngf mediated diseases and disorders
10/19/2011	EP2378288A1 Unnatural reactive amino acid genetic code additions
10/19/2011	EP2377947A1 Method for detecting cancer cells in blood sample
10/19/2011	EP2377946A1 Inclusion bodies, bacterial cells and compositions containing them and uses thereof
10/19/2011	EP2377945A1 Process for producing polylactic acid using genetically modified bacterium
10/19/2011	EP2377941A1 An animal model and a method for producing an animal model
10/19/2011	EP2377940A1 An animal model and a method for producing an animal model
10/19/2011	EP2377939A2 Transgenic plant-based methods for plant pests using RNAi
10/19/2011	EP2377938A1 Capping-prone RNA polymerase enzymes and their applications
10/19/2011	EP2377937A1 Plants with reduced expression of a CLE-like gene having enhanced yield-related traits and a method for making the same
10/19/2011	EP2377936A2 Method for isolation of soluble polypeptides
10/19/2011	EP2377935A1 Method for isolation of soluble polypeptides
10/19/2011	EP2377934A1 Pharmaceutical composition for treatment of cancer and asthma
10/19/2011	EP2377933A1 Probes, liquid phase chips and methods for detecting pik3ca gene mutations
10/19/2011	EP2377932A1 ANTI-Siglec-15 ANTIBODY
10/19/2011	EP2377931A1 Variants of glycoside hydrolases
10/19/2011	EP2377930A1 A group of esterases for the enantioselective production of fine and speciality chemicals
10/19/2011	EP2377926A1 Chondrocyte-like cell, and method for producing same
10/19/2011	EP2377921A1 Method for obtaining pancreatic progenitor cell using neph3
10/19/2011	EP2377917A1 Microinjection apparatus and microinjection method
10/19/2011	EP2377891A1 Diagnosis and treatment of cancer using anti-lgr7 antibody
10/19/2011	EP2377890A2 Antibodies
10/19/2011	EP2377889A2 Antibodies
10/19/2011	EP2377879A1 N-terminal HPV E7 fusion proteins
10/19/2011	EP2377873A1 RNAi modulation of ApoB and uses thereof
10/19/2011	EP2377849A2 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient
10/19/2011	EP2377559A1 Targeting cells with altered microRNA expression
10/19/2011	EP2377558A2 Composition for improving inflammatory disease using abh antigens
10/19/2011	EP2376923A2 Methods for detection of sepsis
10/19/2011	EP2376659A2 Methods, compositions, and kits for detecting allelic variants
10/19/2011	EP2376656A2 Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis
10/19/2011	EP2376643A1 Method for producing beta-santalene
10/19/2011	EP2376641A1 Methods of modulating the sex of avians
10/19/2011	EP2376640A1 Methods and compositions for use of a coccidiosis vaccine
10/19/2011	EP2376639A1 Pcv 2-based methods and compositions for the treatment of pigs
10/19/2011	EP2376638A2 Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms
10/19/2011	EP2376637A1 Use of double stranded rna to increase the efficiency of targeted gene alteration in plant protoplasts
10/19/2011	EP2376636A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt9 polypeptides
10/19/2011	EP2376635A1 Plant root-specific nematode resistance
10/19/2011	EP2376634A1 Process for the enzymatic production of cyclic diguanosine monophosphate employing a diguanylate cyclase comprising a mutated rxxd motif
10/19/2011	EP2376633A1 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
10/19/2011	EP2376632A1 Compositions, methods and related uses for cleaving modified dna
10/19/2011	EP2376631A1 Method for analysis of nucleic acid populations
10/19/2011	EP2376622A2 Green process and compositions for producing poly(5hv) and 5 carbon chemicals
10/19/2011	EP2376620A1 Conversion of hexuronic acid to hexaric acid
10/19/2011	EP2376532A2 Organic compounds
10/19/2011	EP2376526A1 Modified streptococcus pneumoniae pneumolysin (ply) polypeptides
10/19/2011	EP2376091A2 Novel targets for treatment of hypercholesterolemia
10/19/2011	EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011	EP2169058A9 Expression enhancing intron sequences
10/19/2011	EP2166102A9 Expression enhancing intron sequences
10/19/2011	EP2166101A9 Expression enhancing intron sequences
10/19/2011	EP2166100A9 Expression enhancing intron sequences
10/19/2011	EP2166099A9 Expression enhancing intron sequences
10/19/2011	EP2090652B1 Method for detection of hop latent virus, primer set for the detection, and kit for the detection

1 ... 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 ... 4023